
1. General Information
Hertab 250mg Tablet is a prescription anti-cancer medicine containing Lapatinib 250mg. It is designed to target specific proteins involved in the growth and multiplication of cancer cells. It may be prescribed as part of combination therapy depending on the patient's cancer type, previous treatment, and medical condition.
Product highlights:
- Brand: Hertab 250mg Tablet
- Generic name: Lapatinib
- Strength: 250mg
- Dosage form: Tablet
- Therapeutic class: Targeted anti-cancer medicine / tyrosine kinase inhibitor
- Primary indication: Certain HER2-positive breast cancers
- Manufacturer/marketer: Hetero Healthcare
- Prescription medicine: Yes
2. Product Information
Lapatinib works by inhibiting signaling pathways associated with HER2 and EGFR, which can contribute to cancer-cell growth. Hertab may be used with medicines such as capecitabine or letrozole, depending on the clinical indication.
The medicine should be stored according to the manufacturer's instructions; a commonly listed storage recommendation is below 30°C.
3. Uses of Hertab 250mg
Hertab 250mg is primarily used for:
- HER2-positive advanced breast cancer
- HER2-positive metastatic breast cancer
- Certain breast cancers where lapatinib is indicated as part of combination treatment
- Treatment with capecitabine in certain previously treated patients
- Treatment with letrozole in certain postmenopausal patients with HER2-positive, hormone-receptor-positive metastatic breast cancer
4. Benefits of Hertab 250mg
The principal benefit of Hertab is its targeted mechanism of action. Lapatinib blocks signaling through HER2 and EGFR, helping inhibit signals that promote cancer-cell growth and multiplication. This can make it an important component of treatment for appropriately selected patients with HER2-positive breast cancer.
Important: It should only be used for the cancer indication and treatment regimen prescribed by an oncologist.
5. Side Effects
Hertab can cause side effects, and their severity varies between patients. Reported effects include:
- Diarrhea
- Nausea
- Vomiting
- Fatigue or weakness
- Headache
- Rash
- Abdominal discomfort
- Back pain
- Cough or breathing difficulties
- Loss of appetite
- Mouth inflammation/sores
- Joint or muscle pain
- Insomnia
- Changes in liver function
Some reactions can be serious, particularly severe diarrhea, liver toxicity, heart-related effects, and serious skin or hypersensitivity reactions, so medical monitoring is important.
6. Common Side Effects
Commonly reported side effects include:
- Diarrhea
- Nausea
- Vomiting
- Headache
- Fatigue
- Rash
- Back pain
- Cough
- Decreased appetite
- Weakness
- Stomatitis/mouth inflammation
- Dry skin
- Hair loss
- Indigestion
If diarrhea becomes severe or persistent, contact the treating healthcare professional promptly.
7. How to Use Hertab 250mg
Take Hertab exactly according to your oncologist's prescription.
General administration guidance includes:
- Swallow the tablet whole with water.
- Do not crush, chew, or break it.
- Take it consistently in relation to food.
- Product information commonly recommends taking it on an empty stomach, approximately 1 hour before or 2 hours after food.
- Do not change the dose or treatment duration without medical advice.
- If a dose is missed, follow your healthcare professional's instructions rather than taking an extra dose.
8. How Hertab 250mg Works
Hertab contains Lapatinib, which is a tyrosine kinase inhibitor. It targets HER2 and EGFR signaling pathways.
These receptors can send signals that encourage cancer cells to grow and multiply. By inhibiting these pathways, lapatinib can reduce the signaling responsible for cancer-cell proliferation and help slow cancer progression.
9. Safety Advice
- Prescription use: Use only under the supervision of an oncologist.
- Liver: Inform your doctor about existing liver disease. Liver function may need monitoring because lapatinib can cause hepatotoxicity.
- Heart: Tell your doctor about previous heart problems; cardiac monitoring may be required.
- Pregnancy: Lapatinib may harm a developing fetus. Inform your doctor if you are pregnant or planning pregnancy.
- Breastfeeding: Breastfeeding is generally not recommended during treatment.
- Kidneys: Tell your healthcare professional about kidney disease before treatment.
- Drug interactions: Provide your doctor with a complete list of prescription medicines, OTC medicines, vitamins, and supplements because lapatinib can interact with other medicines.
- Diarrhea: Persistent or severe diarrhea requires prompt medical attention.
- Driving: Avoid driving or operating machinery if you experience dizziness, weakness, or other effects that impair alertness.
10. Frequently Asked Questions (FAQs)
Q1. What is Hertab 250mg used for?
Hertab 250mg is primarily used for certain advanced or metastatic HER2-positive breast cancers.
Q2. What is the generic ingredient in Hertab 250mg?
The active ingredient is Lapatinib 250mg.
Q3. Is Hertab 250mg a chemotherapy medicine?
It is a targeted anti-cancer medicine, specifically a tyrosine kinase inhibitor, rather than a conventional cytotoxic chemotherapy drug.
Q4. Can Hertab be taken with other cancer medicines?
Yes. Depending on the indication, lapatinib may be prescribed with medicines such as capecitabine or letrozole. The combination should be determined by an oncologist.
Q5. Should Hertab be taken with food?
It is generally taken on an empty stomach, with the dose administered consistently in relation to meals. Follow your doctor's specific instructions.
Q6. Can Hertab cause diarrhea?
Yes. Diarrhea is one of the commonly reported side effects and can occasionally become severe.
Q7. Can Hertab affect the liver?
Yes. Lapatinib can cause liver toxicity, which is why your doctor may monitor liver function during treatment.
Q8. Can Hertab be used during pregnancy?
It is not generally recommended during pregnancy because it may cause fetal harm. Discuss contraception and pregnancy plans with your doctor.
11. Substitutes for Hertab 250mg
Possible lapatinib 250mg brand alternatives include:
- Her-Tinib 250mg
- Herduo 250mg
- Bretolap 250mg
- Libset
- Combinib 250mg
- Etibo 250mg
Availability and approved indications can differ by country. A substitute should not be selected or switched without confirmation from the prescribing doctor or pharmacist.
12. SEO Keywords
Primary keywords:
- Hertab 250mg Tablet
- Hertab 250mg Tablet exporter
- Hertab 250mg supplier
- Hertab 250mg wholesaler
- Hertab 250mg Lapatinib
- Lapatinib 250mg Tablet
- Lapatinib 250mg exporter from India
- Lapatinib 250mg pharmaceutical supplier
- Hertab 250mg medicine exporter
- Hertab 250mg tablets supplier India
Long-tail B2B SEO keywords:
- Hertab 250mg Tablet exporter from Nagpur India
- Hertab 250mg Lapatinib tablets supplier from India
- Hertab 250mg Tablet pharmaceutical exporter India
- Lapatinib 250mg Tablet wholesale supplier India
- Hertab 250mg anti cancer medicine exporter
- Hertab 250mg breast cancer medicine supplier
- Lapatinib 250mg medicine exporter to USA
- Hertab 250mg exporter to UK
- Lapatinib 250mg supplier to Australia
- Hertab 250mg pharmaceutical supplier to Canada
- Hertab 250mg medicine exporter to Singapore
- Lapatinib 250mg supplier to South Korea
- Hertab 250mg exporter to UAE
- Hertab 250mg Tablet international pharmaceutical supplier
- Lapatinib 250mg anti cancer medicine exporter from India
- Hertab 250mg bulk pharmaceutical supplier
- Hertab 250mg B2B medicine supplier India
- Hertab 250mg tablets international distributor
- Lapatinib 250mg oncology medicine exporter India
- Hertab 250mg oncology pharmaceutical supplier
Keywords







